Reprogramming immunomodulation using AI to cure cancer

Discovering next-generation immunotherapies for cancer requires a cutting-edge technology stack that combines advanced phenotypic screening with AI-driven insights to decode cellular communication.

Our core technology combines a proprietary wet-lab platform, PHENOMS (Phenotypic Screening + Multispecific Biologics), with the revolutionary TRAILBLAZER AI framework, creating an integrated system to explore and manipulate immune signaling networks.

We DISCOVER&DERISK.